Literature DB >> 11829342

Morphological and biochemical correlations of abnormal tau filaments in progressive supranuclear palsy.

Makio Takahashi1, Karen M Weidenheim, Dennis W Dickson, Hanna Ksiezak-Reding.   

Abstract

Progressive supranuclear palsy (PSP) is characterized by specific filamentous tau inclusions present in 3 types of cells including oligodendrocytes (coiled bodies), astrocytes (tufted astrocytes), and neurons (neurofibrillary tangles; NFTs). To correlate the morphological features and biochemical composition of tau in the inclusions, we examined tau filament-enriched fractions isolated from selected brain regions. Frontal and cerebellar white matter manifested a predominance of coiled bodies. The isolated fractions contained straight, 14-nm-wide filaments of relatively smooth appearance. Caudate nucleus and motor cortex with numerous tufted astrocytes contained mostly straight, but irregular, 22-nm-wide filaments with jagged contours. Perirhinal cortex and hippocampus, rich in NFTs, contained 22-nm-wide filaments that were twisted at 80-nm intervals. Among the regions, those with tufted astrocytes showed the most heterogeneity in the ultrastructure of filaments. In all regions, isolated filaments were immunolabeled with PHF-1, Tau 46, and AT8. Fractions from all regions showed 2 PHF-1 immunoreactive bands of 64 and 68 kDa, while an additional band of 60 kDa was detected in NFT-enriched regions. All fractions, in varying extents, showed Tau-1-immunoreactive bands between 45-64 kDa. The results indicate that the 3 types of PSP tau inclusions vary in the ultrastructure although with some overlapping features. Neuronal and glial inclusions also vary in the biochemical profile of tau protein. These differences may depend on the metabolism of tau in the diseased oligodendrocytes, astrocytes, and neurons.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11829342     DOI: 10.1093/jnen/61.1.33

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  16 in total

1.  Tau protein expression in adult bovine oligodendrocytes: functional and pathological significance.

Authors:  Hanna Ksiezak-Reding; Muhammad Farooq; Liang-sheng Yang; Dennis W Dickson; Patrizia LoPresti
Journal:  Neurochem Res       Date:  2003-09       Impact factor: 3.996

2.  Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases.

Authors:  Nicholas M Kanaan; Gerardo A Morfini; Nichole E LaPointe; Gustavo F Pigino; Kristina R Patterson; Yuyu Song; Athena Andreadis; Yifan Fu; Scott T Brady; Lester I Binder
Journal:  J Neurosci       Date:  2011-07-06       Impact factor: 6.167

3.  The MAPT H1 haplotype is associated with tangle-predominant dementia.

Authors:  Ismael Santa-Maria; Aya Haggiagi; Xinmin Liu; Jessica Wasserscheid; Peter T Nelson; Ken Dewar; Lorraine N Clark; John F Crary
Journal:  Acta Neuropathol       Date:  2012-07-17       Impact factor: 17.088

Review 4.  Therapy and clinical trials in frontotemporal dementia: past, present, and future.

Authors:  Richard M Tsai; Adam L Boxer
Journal:  J Neurochem       Date:  2016-06-15       Impact factor: 5.372

5.  GSPE interferes with tau aggregation in vivo: implication for treating tauopathy.

Authors:  Ismael Santa-Maria; Carmen Diaz-Ruiz; Hanna Ksiezak-Reding; Alice Chen; Lap Ho; Jun Wang; Giulio Maria Pasinetti
Journal:  Neurobiol Aging       Date:  2011-11-04       Impact factor: 4.673

6.  Maturation of neuronal AD-tau pathology involves site-specific phosphorylation of cytoplasmic and synaptic tau preceding conformational change and fibril formation.

Authors:  Luis Aragão Gomes; Valerie Uytterhoeven; Diego Lopez-Sanmartin; Sandra O Tomé; Thomas Tousseyn; Rik Vandenberghe; Mathieu Vandenbulcke; Christine A F von Arnim; Patrik Verstreken; Dietmar Rudolf Thal
Journal:  Acta Neuropathol       Date:  2021-01-11       Impact factor: 17.088

Review 7.  Development of a grape seed polyphenolic extract with anti-oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathies.

Authors:  Giulio Maria Pasinetti; Hanna Ksiezak-Reding; Ismael Santa-Maria; Jun Wang; Lap Ho
Journal:  J Neurochem       Date:  2010-07-27       Impact factor: 5.372

8.  Paired helical filaments from Alzheimer disease brain induce intracellular accumulation of Tau protein in aggresomes.

Authors:  Ismael Santa-Maria; Merina Varghese; Hanna Ksiezak-Reding; Anastasiya Dzhun; Jun Wang; Giulio M Pasinetti
Journal:  J Biol Chem       Date:  2012-04-10       Impact factor: 5.157

9.  18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.

Authors:  David N Soleimani-Meigooni; Leonardo Iaccarino; Renaud La Joie; Suzanne Baker; Viktoriya Bourakova; Adam L Boxer; Lauren Edwards; Rana Eser; Maria-Luisa Gorno-Tempini; William J Jagust; Mustafa Janabi; Joel H Kramer; Orit H Lesman-Segev; Taylor Mellinger; Bruce L Miller; Julie Pham; Howard J Rosen; Salvatore Spina; William W Seeley; Amelia Strom; Lea T Grinberg; Gil D Rabinovici
Journal:  Brain       Date:  2020-12-05       Impact factor: 13.501

10.  4',6-Diamidino-2-Phenylindole Distinctly Labels Tau Deposits.

Authors:  Chengyu Li; Tetsuya Takahashi; Tejashwi Shrestha; Eiji Kinoshita; Tomoyasu Matsubara; Masayasu Matsumoto; Hirofumi Maruyama
Journal:  J Histochem Cytochem       Date:  2018-08-14       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.